Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1983;16(Suppl 2):347S–351S. doi: 10.1111/j.1365-2125.1983.tb02309.x

Residual effects of flurazepam and brotizolam on psychomotor performance

H Krueger, W Müller-Limmroth
PMCID: PMC1428207  PMID: 6661380

Abstract

1 Residual effects of brotizolam (0.25 mg) and flurazepam (30 mg) were studied in healthy young adults. Performance and subjective assessments were observed from 7 to 8 h after overnight ingestion, and effects were compared with that of placebo.

2 Visuo-motor coordination, visuo-mental processing time, visuo-motor reaction time and reading errors were not impaired with brotizolam.

3 There were residual effects with 30 mg flurazepam. Visuo-motor coordination, visuo-mental processing time, visuo-motor reaction time, and reading errors were impaired compared with placebo and 0.25 mg brotizolam.

4 Subjective assessments of performance correlated with measured performance. There was a decrease with flurazepam (visuo-motor coordination and visuo-mental processing time) compared with placebo.

Keywords: flurazepam, brotizolam, residual effects, psychomotor performance

Full text

PDF
347S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Jones D. M., Lewis M. J., Spriggs T. L. The effects of low doses of diazepam on human performance in group administered tasks. Br J Clin Pharmacol. 1978 Oct;6(4):333–337. doi: 10.1111/j.1365-2125.1978.tb00860.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Kubicki S. Elektroenzephalographische Dosis- und Schlafprofilbeurteilung eines Hypnotikums aus der Reihe der Triazolothienodiazepine. EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb. 1979 Jun;10(2):95–100. [PubMed] [Google Scholar]
  3. Nicholson A. N., Stone B. M., Pascoe P. A. Studies on sleep and performance with a triazolo-1, 4-thienodiazepine (brotizolam). Br J Clin Pharmacol. 1980 Jul;10(1):75–81. doi: 10.1111/j.1365-2125.1980.tb00504.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Saletu B., Grünberger J., Volavka J., Berner P. Classification and bioavailability studies with WE 941 by quantitative pharmaco-EEG and clinical analyses. Arzneimittelforschung. 1979;29(4):700–704. [PubMed] [Google Scholar]
  5. von Zerssen D., Koeller D. M., Rey E. R. Die Befindlichkeits-Skala (B-S)--ein einfaches Instrument zur Objektivierung von Befindlichkeitsstörungen, insbesondere im Rahmen von Längsschnittuntersuchungen. Arzneimittelforschung. 1970 Jul;20(7):915–918. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES